argiotoxin-636 has been researched along with ozagrel in 1 studies
Studies (argiotoxin-636) | Trials (argiotoxin-636) | Recent Studies (post-2010) (argiotoxin-636) | Studies (ozagrel) | Trials (ozagrel) | Recent Studies (post-2010) (ozagrel) |
---|---|---|---|---|---|
53 | 0 | 7 | 529 | 31 | 37 |
Protein | Taxonomy | argiotoxin-636 (IC50) | ozagrel (IC50) |
---|---|---|---|
cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 3.43 | |
Thromboxane-A synthase | Homo sapiens (human) | 0.0864 | |
Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bengeloune, AH; Bertin, D; De Pomyers, H; Gigmes, D; Luis, J; Mabrouk, K; Roudaut, H; Verdoni, M | 1 |
1 other study(ies) available for argiotoxin-636 and ozagrel
Article | Year |
---|---|
ArgTX-636, a polyamine isolated from spider venom: A novel class of melanogenesis inhibitors.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Indoleacetic Acids; Melanins; Mice; Molecular Structure; Polyamines; Spider Venoms; Structure-Activity Relationship | 2016 |